Range Low Price High Price Comment
30 days $1.11 $1.63 Monday, 29th Apr 2024 CLSD stock ended at $1.29. This is 3.73% less than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 4.69% from a day low at $1.28 to a day high of $1.34.
90 days $1.11 $2.12
52 weeks $0.650 $2.12

Historical Clearside BioMedical, Inc prices

Date Open High Low Close Volume
Jun 23, 2016 $7.00 $7.00 $6.85 $6.90 22 900
Jun 22, 2016 $6.87 $7.10 $6.75 $7.10 58 000
Jun 21, 2016 $7.03 $7.10 $6.85 $6.97 42 700
Jun 20, 2016 $7.10 $7.15 $7.00 $7.04 10 900
Jun 17, 2016 $6.92 $7.10 $6.90 $7.10 27 300
Jun 16, 2016 $7.06 $7.15 $6.94 $7.00 28 100
Jun 15, 2016 $6.82 $7.11 $6.76 $7.01 23 100
Jun 14, 2016 $6.94 $6.99 $6.75 $6.99 28 700
Jun 13, 2016 $6.92 $6.95 $6.72 $6.90 67 900
Jun 10, 2016 $7.02 $7.02 $6.78 $6.90 51 000
Jun 09, 2016 $6.80 $6.96 $6.74 $6.96 29 900
Jun 08, 2016 $7.00 $7.00 $6.86 $7.00 147 300
Jun 07, 2016 $7.00 $7.02 $6.89 $6.92 56 700
Jun 06, 2016 $7.06 $7.41 $6.85 $7.00 245 500
Jun 03, 2016 $7.20 $7.51 $7.00 $7.06 569 900
Jun 02, 2016 $8.00 $8.45 $7.14 $7.25 1 979 400
Click to get the best stock tips daily for free!

About Clearside BioMedical, Inc

Clearside BioMedical Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an i... CLSD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT